eMedicine Specialties > Obstetrics and Gynecology > General Gynecology
Adnexal Tumors
Updated: Oct 16, 2008
Introduction
The normal functioning ovary produces a follicular cyst 6-7 times each year. In most cases, these functional masses are self-limiting and resolve within the duration of a normal menstrual cycle. In rare situations, they persist longer or become enlarged. At this point, they represent a pathological condition.
Adnexal masses present a diagnostic dilemma; the differential diagnosis is extensive, with most masses representing benign processes.1,2,3 However, without histopathologic tissue diagnosis, a definitive diagnosis is generally precluded. Physicians must evaluate the likelihood of a pathologic process using clinical and radiologic information and balance the risk of surgical intervention for a benign versus malignant process.
Since ovaries produce physiologic cysts in menstruating women, the likelihood of a benign process is higher. In contrast, the presence of an adnexal mass in prepubertal girls and postmenopausal women heightens the risk of a pathologic etiology.
For related information, see Medscape's Women's Sexual Health Resource Center.
History of the Procedure
In the past, physicians relied on the findings of a pelvic examination to diagnose an adnexal mass. With the introduction of imaging modalities including transabdominal or vaginal ultrasonography, Doppler color scans, and MRI scans, more characterization of the internal structure of the mass (ie wall complexity, mass contents) is possible.4,5,6,7 Although not definitive, these findings can help determine whether a mass appears more consistent with a physiologic cyst or neoplastic process.
Problem
The following masses pose the greatest concern:
- Those that have a complex internal structure
- Those that have solid components
- Those that are associated with pain
- Masses in prepubescent or postmenopausal women
- Large cysts (A variety of cut off sizes have been proposed. In some institutions, unilocular cysts up to 10 cm have been followed conservatively, even in postmenopausal women.7 However, complex cysts in this same group of patients generally heightens suspicion, regardless of size.)
- In menstruating women, those who persist beyond the length of a normal menstrual cycle without typical characteristics of a benign process such as a hemorrhagic cyst
Frequency
Determining the true frequency of adnexal masses is impossible because most adnexal cysts develop and resolve without clinical detection. When assessing the clinical significance of an adnexal mass, considering several age groups is important.
In girls younger than 9 years, 80% of ovarian masses are malignant and are generally germ cell tumors.8,9 During adolescence, 50% of adnexal neoplasms are adult cystic teratomas. Women with gonads that contain a Y chromosome have a 25% chance of developing a malignant neoplasm. Endometriosis is uncommon in adolescent women but may be present in as many as 50% of those who present with a painful mass. In sexually active adolescents, one must always consider a tubo-ovarian abscess as the cause of an adnexal mass.10,11
In women of reproductive age who have had adnexal masses removed surgically, most are benign cysts or masses. Ten percent of masses are malignant12 ; many tumors in patients younger than 30 years are of low malignant potential. Thirty-three percent are adult cystic teratomas, and 25% are endometriomas. The rest are serous or mucinous cystadenomas or functional cysts.
Historically, postmenopausal women with clinically detectable ovaries were felt to be at great risk of having a malignant neoplasm. With the introduction of radiologic testing, many smaller, simple cystic masses have been identified; therefore, the risk of malignancy may be only 20-30%. The differential includes benign cysts, metastatic versus primary ovarian malignancies, tubal cysts and neoplasms such as paratubal cysts, hydrosalpinx, or rarely fallopian tube cancer. Radiologic testing allows the architecture of the mass to be evaluated, which decreases the need to operate on benign masses in this age group.
In all age groups, the physician must also consider the possibility of uterine masses or structural deformities. Pregnancy-related adnexal masses, including ectopic pregnancy, theca lutein cysts, corpus luteum cysts, and luteomas, must be considered in all premenopausal women.13,14
Pathophysiology
The pathophysiology is not well understood for most adnexal masses; however, some theories have been proposed. Functional cysts may be the result of variation in normal follicle formation. Adult cystic teratomas (dermoid) may be the result of an abnormal germ cell. Endometriomas are thought to result from retrograde menstruation or coelomic metaplasia. The exact cause of epithelial neoplasms is unknown, but recent studies have suggested a complex series of molecular genetic changes is involved.
Presentation
The clinical presentation of an adnexal mass can be variable, but patients are often asymptomatic, presenting with masses that are found (1) at the time of a pelvic examination, (2) at the time of a radiologic examination for another diagnosis, or (3) at the time of a surgical procedure. Women who have symptoms may note urinary frequency, pelvic or abdominal pressure, and bowel habit changes due to the mass effect on these organs. Girls younger than 10 years frequently present with pain, as do older women who have infected masses or endometriosis. Adnexal torsion often presents with acute abdominal pain, requiring urgent surgical intervention.
Approximately 10% of ovarian cancers are hereditary. As such, patients with a history suspicious for a hereditary breast-ovarian cancer syndrome (BRCA1 or BRCA2) or hereditary nonpolyposis colorectal cancer syndrome, are at increased risk for development of a malignant mass.20 These patients should also be considered for genetic counseling and evaluation of risk.
As the adnexa are located deep in the pelvis, masses may be palpated with a standard gynecologic examination. However, other factors, such as obesity and size of mass, may limit the use of physical examination.21
Indications
Many adnexal masses present as asymptomatic, small, and simple cystic masses. Most of these resolve spontaneously; therefore, care must be taken to not overreact to such a finding. Surgeons who rush these women into surgery often create more pathology than they cure. Any surgery performed on adnexal structures can result in impaired fertility.
On the other hand, these same asymptomatic masses can be early ovarian cancers that require immediate attention. The use of radiologic testing often helps determine which women require attention (see Imaging Studies). The use of cancer antigen 125 (CA-125) can be used in combination with radiologic testing to stratify the risk of adnexal masses. However, in the general population, the use of CA-125 to screen for the presence of cancer should be discouraged.15 A large Swedish study has shown that approximately 50% of women with stage I ovarian cancer have a normal CA-125 test value. In addition, a high false-positive rate can be caused by pregnancy, endometriosis, cirrhosis, and pelvic or other intra-abdominal infections.16,17,18
Relevant Anatomy
The term adnexa is derived from the pleural form of the Latin word meaning "appendage." The adnexa of the uterus include the ovaries, fallopian tubes, and structures of the broad ligament. Most frequently, adnexal masses refer to ovarian masses or cysts; however, paratubal cysts, hydrosalpinx, and other nonovarian masses are also included within the broader definition of adnexal masses.
Several other anatomical structures are important to identify, both for the evaluation of other sources of masses within the pelvis and during surgical procedures to prevent damage to nearby organs and structures. The uterus is central to both adnexal regions and can be the source of a pelvic mass. For instance, exophytic, pedunculated fibroids can mimic adnexal masses on preoperative imaging. The rectum and bladder are located posterior and anterior to the adnexal regions. Both can be the source of pelvic masses, although this is less frequent. In addition, they must be protected from injury when adnexal surgery is performed. The ureters are located near the ovarian blood supply and can be damaged easily during adnexal surgery. Many of the pathologic processes associated with adnexal masses can alter the location of the ureters, increasing the chance of damage.
Contraindications
Many adnexal masses present as asymptomatic, small, simple cystic masses, most of which can resolve spontaneously. Considering nonsurgical management and follow-up in patients with low-risk adnexal masses is important to avoid unnecessary procedures, particularly as procedures performed on adnexal structures may result in impaired fertility.
Many adnexal masses can be removed using laparoscopic techniques and are associated with little postoperative complexity.19 However, in those women with significant preexisting medical problems and/or cancer, major postoperative problems can be encountered and preoperative evaluation is important to assess clearance for surgery (see Postoperative Details and Complications).
More on Adnexal Tumors |
Overview: Adnexal Tumors |
| Workup: Adnexal Tumors |
| Treatment: Adnexal Tumors |
| Follow-up: Adnexal Tumors |
| References |
| Next Page » |
References
ACOG Practice Bulletin. Management of adnexal masses. Obstet Gynecol. Jul 2007;110(1):201-14. [Medline].
Drake J. Diagnosis and management of the adnexal mass. Am Fam Physician. May 15 1998;57(10):2471-6, 2479-80. [Medline].
Gallup DG, Talledo E. Management of the adnexal mass in the 1990s. South Med J. Oct 1997;90(10):972-81. [Medline].
Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis. Radiology. Jan 2000;214(1):39-46. [Medline].
Alcazar JL, Ruiz-Perez ML, Errasti T. Transvaginal color Doppler sonography in adnexal masses: which parameter performs best?. Ultrasound Obstet Gynecol. Aug 1996;8(2):114-9. [Medline].
Castillo G, Alcázar JL, Jurado M. Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women. Gynecol Oncol. Mar 2004;92(3):965-9. [Medline].
Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ, van Nagell JR Jr. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol. Sep 2003;102(3):594-9. [Medline].
Zalel Y, Piura B, Elchalal U, Czernobilsky B, Antebi S, Dgani R. Diagnosis and management of malignant germ cell ovarian tumors in young females. Int J Gynaecol Obstet. Oct 1996;55(1):1-10. [Medline].
Barber HR, Graber EA. Gynecological tumors in childhood and adolescence. Obstet Gynecol Surv. May 1973;28(5):suppl:357-81. [Medline].
Pfeifer SM, Gosman GG. Evaluation of adnexal masses in adolescents. Pediatr Clin North Am. Jun 1999;46(3):573-92. [Medline].
Slap GB, Forke CM, Cnaan A, et al. Recognition of tubo-ovarian abscess in adolescents with pelvic inflammatory disease. J Adolesc Health. Jun 1996;18(6):397-403. [Medline].
Kinkel K, Lu Y, Mehdizade A, Pelte MF, Hricak H. Indeterminate ovarian mass at US: incremental value of second imaging test for characterization--meta-analysis and Bayesian analysis. Radiology. Jul 2005;236(1):85-94. [Medline].
Clement PB. Tumor-like lesions of the ovary associated with pregnancy. Int J Gynecol Pathol. Apr 1993;12(2):108-15. [Medline].
Chiang G, Levine D. Imaging of adnexal masses in pregnancy. J Ultrasound Med. Jun 2004;23(6):805-19. [Medline].
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Gynecol Oncol. Dec 2002;87(3):237-9. [Medline].
Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril. Dec 1998;70(6):1101-8. [Medline].
Devarbhavi H, Kaese D, Williams AW, Rakela J, Klee GG, Kamath PS. Cancer antigen 125 in patients with chronic liver disease. Mayo Clin Proc. Jun 2002;77(6):538-41. [Medline].
Topalak O, Saygili U, Soyturk M, Karaca N, Batur Y, Uslu T, et al. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study. Gynecol Oncol. Apr 2002;85(1):108-13. [Medline].
Canis M, Pouly JL, Wattiez A, et al. Laparoscopic management of adnexal masses suspicious at ultrasound. Obstet Gynecol. May 1997;89(5 Pt 1):679-83. [Medline].
Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G. Hereditary ovarian cancer. Crit Rev Oncol Hematol. Jul 23 2008;[Medline].
Padilla LA, Radosevich DM, Milad MP. Limitations of the pelvic examination for evaluation of the female pelvic organs. Int J Gynaecol Obstet. Jan 2005;88(1):84-8. [Medline].
Carlson KJ, Skates SJ, Singer DE. Screening for ovarian cancer. Ann Intern Med. Jul 15 1994;121(2):124-32. [Medline].
Twickler DM, Forte TB, Santos-Ramos R, et al. The Ovarian Tumor Index predicts risk for malignancy. Cancer. Dec 1 1999;86(11):2280-90. [Medline].
DePriest PD, Gallion HH, Pavlik EJ, et al. Transvaginal sonography as a screening method for the detection of early ovarian cancer. Gynecol Oncol. Jun 1997;65(3):408-14. [Medline].
Einhorn N. Ovarian cancer. Acta Oncol. 1996;35 Suppl 7:86-92. [Medline].
Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. Oct 2002;87(1):1-7. [Medline].
Haefner HK, Roberts JA, Schmidt R. The university experience of clinical and pathological findings of ovarian neoplasms in children and adolescents. Ped Adoles Gynecol. 1992;5:182-6.
Maiman M, Seltzer V, Boyce J. Laparoscopic excision of ovarian neoplasms subsequently found to be malignant. Obstet Gynecol. Apr 1991;77(4):563-5. [Medline].
Nezhat FR, Tazuke S, Nezhat CH, et al. Laparoscopy during pregnancy: a literature review. JSLS. Jan-Mar 1997;1(1):17-27. [Medline].
Spanos WJ. Preoperative hormonal therapy of cystic adnexal masses. Am J Obstet Gynecol. Jun 15 1973;116(4):551-6. [Medline].
Timmerman D, Bourne TH, Tailor A, et al. A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model. Am J Obstet Gynecol. Jul 1999;181(1):57-65. [Medline].
Further Reading
Keywords
adnexal mass, pelvic mass, ovarian mass, pelvic masses, ovarian masses, ovarian cysts, ovarian neoplasms, fallopian tube masses, fallopian tube neoplasms, follicular cyst, endometriosis, ovarian cancer, functional cysts, nonfunctional cysts, germ cell tumor, adult cystic teratoma, dermoid cyst
Overview: Adnexal Tumors